2m 2m 2m 2m 2m 2m 2m
ANAPTYSBIO (ANAB)
NASDAQ
$53.15-$0.21 (-0.39%)
Price as of Aug 03, 2026 11:32 AM EDT- $1.6BMarket Cap
- 116.12%1-Year Change
- BiotechnologyIndustry
ANAPTYSBIO (ANAB)
$53.15-$0.21 (-0.39%)
ANAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $53.36 | ||
Change | -$1.68 (-3.05%) | ||
Open | $54.10 | ||
High | $54.52 | ||
Low | $52.23 | ||
Previous Close | $55.04 | ||
Volume | 451,375 | ||
30-Day Average Volume | 805,752 | ||
1-Week Change | -1.46% | ||
1-Month Change | -20.95% | ||
1-Year Change | 116.12% | ||
3-Year Change | 170.73% | ||
5-Year Change | 132.20% | ||
Fundamentals | |||
Shares Outstanding | 29.6M | ||
Total Assets | $329.7M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $25.6M | ||
Net Income | -$52.9M | ||
Free Cash Flow | -$25.9M | ||
EBIT | -$52.8M | ||
EBITDA | -$52.7M | ||
Net Working Capital | $274.4M | ||
EPS | -$1.84 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 52 | ||
P/B | 124 | ||
P/E | -29 | ||
PEG | 0 | ||
Price/Free Cash Flow | -61 | ||
Price/Operating Cash Flow | -61 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue